Cancer Family
Melanocytic Neoplasm
CI-CAN-00000026Explore in graph →
Non-malignant610 active trials13 approved drugs233 evidence items
- NCIt
- C7058
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000026Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00005633 | Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00005815 | Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 1 / Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00313235 | Combined Modality Treatment for Patients With Stage IV Melanoma | completed | Phase 1 / Phase 2 | 41 | Baylor Research InstituteOTHER | 1 | Jun 13, 2013 | clinicaltrials |
| NCT01245556 | Safety and Efficacy Study of BMS-908662 in Combination With Ipilimumab in Subjects With Advanced Melanoma | completed | Phase 1 | 8 | Bristol-Myers SquibbINDUSTRY | 1 | Jun 12, 2013 | clinicaltrials |
| NCT00004016 | Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors | completed | Phase 1 | — | University of RochesterOTHER | 1 | Jun 6, 2013 | clinicaltrials |
| NCT00101270 | Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00005943 | Gene Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 1 | — | University of Colorado, DenverOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00112476 | Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT00217542 | Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery | completed | Phase 1 | 42 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT00006368 | Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer | completed | Phase 1 | 60 | Novartis PharmaceuticalsINDUSTRY | 1 | May 1, 2013 | clinicaltrials |
| NCT00112216 | Immunotherapy of Melanoma Patients | completed | Phase 1 | 9 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Apr 24, 2013 | clinicaltrials |
| NCT00112229 | Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma Patients | completed | Phase 1 | 29 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Apr 22, 2013 | clinicaltrials |
| NCT00004184 | Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 1 / Phase 2 | 50 | University of Alabama at BirminghamOTHER | 0 | Apr 12, 2013 | clinicaltrials |
| NCT00089362 | Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00091143 | Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma | completed | Phase 1 | 20 | Providence Cancer Center, Earle A. Chiles Research InstituteOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT00003229 | Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal | completed | Phase 1 / Phase 2 | — | Duke UniversityOTHER | 1 | Mar 25, 2013 | clinicaltrials |
| NCT00004244 | Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Mar 21, 2013 | clinicaltrials |
| NCT00104845 | Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma | completed | Phase 1 | 19 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 12, 2013 | clinicaltrials |
| NCT00512889 | Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma | completed | Phase 1 | 9 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 1, 2013 | clinicaltrials |
| NCT00003665 | Vaccine Therapy in Treating Patients With Stage IV Melanoma | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00002754 | Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors | completed | Phase 1 | 6 | Duke UniversityOTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00004148 | Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma | completed | Phase 1 | 12 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00003556 | Vaccine Therapy in Treating Patients With Melanoma | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Feb 8, 2013 | clinicaltrials |
| NCT00030615 | Decitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00204516 | Vaccination With Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens | completed | Phase 1 / Phase 2 | 31 | University Hospital TuebingenOTHER | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00204594 | Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28 | completed | Phase 1 / Phase 2 | 1 | University Hospital TuebingenOTHER | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00970996 | Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma(BCAA) | completed | Phase 1 | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 3, 2013 | clinicaltrials |
| NCT01308762 | A Clinical Study, to Evaluate the Safety and Tolerability of Intradermal IMM-101 in Adult Melanoma Cancer Patients | completed | Phase 1 | 19 | Immodulon Therapeutics LtdINDUSTRY | 1 | Dec 6, 2012 | clinicaltrials |
| NCT00324623 | Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic Melanoma | completed | Phase 1 | 8 | Prof. Serge LeyvrazOTHER | 1 | Nov 20, 2012 | clinicaltrials |
| NCT00005615 | Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa | completed | Phase 1 / Phase 2 | 24 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 25, 2012 | clinicaltrials |
| NCT00798629 | Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured | completed | Phase 1 | 13 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 24, 2012 | clinicaltrials |
| NCT01294735 | Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1) | completed | Phase 1 | 19 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 15, 2012 | clinicaltrials |
| NCT00527761 | Taxotere/Temodar/Cisplatin Study in Melanoma Patients | completed | Phase 1 | 23 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00023647 | Vaccine Therapy in Treating Patients With Stage IV Melanoma | completed | Phase 1 | 26 | Mannkind CorporationINDUSTRY | 1 | Jul 10, 2012 | clinicaltrials |
| NCT00085462 | Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 1 | 61 | National Institutes of Health Clinical Center (CC)NIH | 1 | Jun 22, 2012 | clinicaltrials |
| NCT00846833 | Haploidentical NK Cell Infusion in Malignant Melanoma | completed | Phase 1 / Phase 2 | 12 | Seoul National University HospitalOTHER | 1 | Jun 8, 2012 | clinicaltrials |
| NCT00431275 | Study to Compare Two Formulations of CP-675,206 Monoclonal Antibody | completed | Phase 1 | 85 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00412425 | Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting | completed | Phase 1 / Phase 2 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | May 4, 2012 | clinicaltrials |
| NCT00750399 | Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma | completed | Phase 1 | 10 | The New York Eye Cancer CenterOTHER | 1 | Apr 26, 2012 | clinicaltrials |
| NCT01052142 | Safety Study of a Liposomal Vaccine to Treat Malignant Melanoma | completed | Phase 1 | 12 | Lipotek Pty LtdINDUSTRY | 1 | Apr 11, 2012 | clinicaltrials |
| NCT00438984 | Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma | completed | Phase 1 | 11 | Fred Hutchinson Cancer Research Center/University of Washington Cancer ConsortiumOTHER | 1 | Mar 16, 2012 | clinicaltrials |
| NCT00019019 | Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas | completed | Phase 1 | 70 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00091104 | Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma | completed | Phase 1 | 136 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00111696 | Study of the Tumor Saturation and Biological Activity of MEDI-522 (Abergrin) in Patients With Advanced Malignant Melanoma | completed | Phase 1 | 18 | MedImmune LLCINDUSTRY | 1 | Mar 14, 2012 | clinicaltrials |
| NCT00542893 | A Phase I, Randomized, Open-label, Cross-over, Pharmacokinetic Study of Genasense With and Without Dacarbazine | completed | Phase 1 | — | Genta IncorporatedINDUSTRY | 0 | Mar 13, 2012 | clinicaltrials |
| NCT00451880 | Study of XL281 in Adults With Solid Tumors | completed | Phase 1 | 180 | ExelixisINDUSTRY | 1 | Oct 13, 2011 | clinicaltrials |
| NCT00698100 | Vaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA Vaccines | completed | Phase 1 | 18 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 16, 2011 | clinicaltrials |
| NCT00003690 | Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 48 | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00399113 | Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma | completed | Phase 1 | 12 | Pain TherapeuticsINDUSTRY | 1 | Jul 14, 2011 | clinicaltrials |
| NCT00734188 | Dose Escalation and Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma | completed | Phase 1 | 21 | Pain TherapeuticsINDUSTRY | 1 | Jul 14, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Jun 19, 2013source: clinicaltrials